We have a freshly published paper in Biotechnology Advances. In this work, the authors explore “Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein”.
This work was developed under the scope of the Pure Project, financed by the European Union’s Horizon 2020.
